Consolidated Financial Results
for the Six Months Ended December 20, 2023
[Japanese GAAP]
January 29, 2024
Company name: Genky DrugStores Co., Ltd.
Stock exchange listing: Tokyo Stock Exchange
Code number: 9267
URL: http://www.genkydrugstores.co.jp
Representative: Kenichi Fujinaga, President
Contact: Takeshi Tsunemi, Executive Officer, Treasurer and General Manager, IR Division
Phone: +81-776-67-5240
Scheduled date of filing quarterly securities report: February 2, 2024
Scheduled date of commencing dividend payments: February 27, 2024
Availability of supplementary briefing material on quarterly financial results: Available
Schedule of quarterly financial results briefing session: Scheduled (for institutional investors and analysts)(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Six Months Ended December 20, 2023 (June 21, 2023 to December 20,2023)(1) Consolidated Operating Results(% indicates changes from the previous corresponding period.)
Net income
Net sales
Operating income
Ordinary income
attributable to ownersof parent
Six months ended
Million yen%
Million yen%
Million yen%
Million yen%December 20, 2023
91,967
9.6
4,387
30.4
4,495
26.2
3,087
36.0
December 20, 2022
83,874 10.0
3,364
15.2
3,561
13.9
2,271
6.5
(Note) Comprehensive income: Six months ended December 20, 2023: ¥3,071 million (34.9%)
Six months ended December 20, 2022: ¥2,277 million (7.8%)
Net income
per share
Six months ended
December 20, 2023
December 20, 2022

Diluted net
income per share
Yen

Yen

203.32149.59203.11149.48(2) Consolidated Financial Position
Total assets
Million yen

As of December 20, 2023108,300
As of June 20, 2023
105,912(Reference) Equity: As of December 20, 2023: ¥43,500 million
As of June 20, 2023: ¥40,607 million

Net assets

Equity ratio

Million yen%

43,592
40,681

40.2
38.3

2. Dividends
Annual dividends
1stquarter-end

2ndquarter-end
Yen

3rd
quarter-end
Yen

Year-end

Total

Yen

Yen

Yen

12.50
－－
Fiscal 2022
12.50－
Fiscal 2023
Fiscal 2023－(Forecast)(Note) Revision to the forecast for dividends announced most recently: No

12.50

25.00

12.50

25.00

3. Consolidated Financial Results Forecast for the Fiscal Year Ending June 20, 2024 (June 21, 2023 to June 20,2024)(% indicates changes from the previous corresponding period.)
Net income
Net income
Net sales
Operating income Ordinary income
attributable toper shareowners of parent
Million yen%

Million yen%

Million yen%

Full year
183,000 8.2
8,300 23.7
8,520
20.3
(Note) Revision to the financial results forecast announced most recently: No

Million yen%

Yen

5,800

21.7

381.89Notes:(1) Changes in significant subsidiaries during the period under review (changes in specified subsidiaries resulting inchanges in scope of consolidation): No
Newly consolidated: None (Company Name); Removed from consolidation: None (Company Name)(2) Accounting policies adopted specially for the preparation of quarterly consolidated financial statements: No(3) Changes in accounting policies, changes in accounting estimates and retrospective restatement
1) Changes in accounting policies due to the revision of accounting standards: No
2) Changes in accounting policies other than 1) above: No
3) Changes in accounting estimates: No4) Retrospective restatement: No(4) Total number of issued shares (common stock)1) Total number of issued shares at the end of the period (including treasury stock):
As of December 20, 2023: 15,487,884 shares
As of June 20, 2023: 15,484,384 shares2) Total number of treasury stock at the end of the period:
As of December 20, 2023: 300,414 shares
As of June 20, 2023: 300,414 shares
3) Average number of shares during the period:
Six months ended December 20, 2023: 15,186,888 shares
Six months ended December 20, 2022: 15,182,504 shares* These quarterly financial results are outside the scope of quarterly reviews by a certified public accountant or anaudit corporation.
* Explanation of the proper use of financial results forecast and other notes
The earnings forecasts and other forward-looking statements herein are based on information that is available andcertain assumptions deemed reasonable as of the date of publication of this document. Actual results may differ
significantly from these forecasts due to a wide range of factors.